Randomized clinical trials in Alzheimer's disease have grown substantially in scale and complexity over the past three decades, with modern studies increasingly designed to capture slower and more subtle therapeutic effects. The post Alzheimer’s Studies Evolve with Bigger, Slower Trials appeared first on European Medical Journal.
